- £29.04m
- £15.38m
- £2.19m
REG - Angle PLC - Standard form for notification of major holdings
AnnouncementREG - Angle PLC - Result of 2024 Annual General Meeting
AnnouncementREG - AIM - AIM Notice - 24/06/2024
AnnouncementREG - Angle PLC - Result of open offer
AnnouncementREG - Angle PLC - Posting of 2023 Annual Report & Notice of the AGM
AnnouncementREG - AIM - AIM Notice - 11/06/2024
AnnouncementRCS - Angle PLC - Parsortix and assays being showcased at EACR 2024
AnnouncementREG - Angle PLC - Publication of Circular
AnnouncementREG - Angle PLC - Results of placing and subscription
AnnouncementREG - Angle PLC - Preliminary Results
AnnouncementREG - Angle PLC - Proposed Placing, Subscription and Open Offer
AnnouncementRCS - Angle PLC - Study of ovarian cancer CTCs using Parsortix
AnnouncementREG - Angle PLC - New commercial agreement with large pharma
AnnouncementREG - Angle PLC - New commercial agreement with AstraZeneca
AnnouncementREG - Angle PLC - US and EU patents for innovative CellKeep™ slide
AnnouncementRCS - Angle PLC - Parsortix HER2 assay showcased at AACR 2024
AnnouncementRCS - Angle PLC - Parsortix at European breast cancer conference
AnnouncementRCS - Angle PLC - Potential utility in precision oncology
AnnouncementREG - Angle PLC - Standard form for notification of major holdings
Announcement